Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)

OPEC's Barkindo: Hope Consultations Lead to Consensus
26:24 - OPEC secretary general Mohammad Sanusi Barkindo says he's hopeful of finding consensus in continuing consultations, but Algiers meeting has made progress compared to Doha. He spoke with Bloomberg's Caroline Connan on the sidelines of the IEF meeting in Algiers, Algeria. (Source: Bloomberg)
  • Commerzbank Shares Hit by Talk of Job, Dividend Cuts
  • George Osborne on Brexit, U.K. Economy, BOE, and Trump
  • Osborne Warns of Hard Brexit's 'Severe' Consequences